UCLA develops safer, more effective TB vaccine for HIV-positive people

UCLA scientists engineered a new tuberculosis (TB) vaccine specifically designed for HIV-positive people that was shown to be safer and more potent than the current TB vaccine in preclinical trials.

If you want to include this story in your blog, copy and paste this formatted text: